Corgentech to Present at CIBC World Markets' Annual Biotechnology and Specialty Pharmaceuticals Conference 2006
27 3월 2006 - 10:00PM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., March 27 /PRNewswire-FirstCall/ --
Corgentech Inc. (NASDAQ:CGTK), a biotechnology company, today
announced that John P. McLaughlin, the company's chief executive
officer, will present at CIBC World Markets' Annual Biotechnology
and Specialty Pharmaceuticals Conference on Tuesday, April 4, 2006
at 2:15 p.m., in New York City. To access the live webcast or the
subsequent archived recording, log on to http://www.corgentech.com/
and go to the Investors page, and click on Webcasts. Please connect
to Corgentech's website several minutes prior to the start of the
webcast to ensure adequate time for any software download that may
be necessary. About Corgentech Corgentech is a late-stage
biopharmaceutical company focused on the development and
commercialization of novel therapeutic treatments for pain and
inflammation. The company has four drug candidates in clinical
development for multiple potential indications, the most advanced
of which, ALGRX 3268, has completed Phase 3 clinical trials.
Corgentech is based in South San Francisco, CA. For more
information on the company, please visit
http://www.corgentech.com/. DATASOURCE: Corgentech Inc. CONTACT:
Jennifer Cook Williams of Corgentech Inc., +1-650-624-9600, or ; or
Daryl Messinger of WeissComm Partners, +1-415-999-2361, or , for
Corgentech Inc. Web site: http://www.corgentech.com/
Copyright
Corgentech (NASDAQ:CGTK)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Corgentech (NASDAQ:CGTK)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Corgentech Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Corgentech (MM) News Articles